Fact-checked by Grok 2 weeks ago

TYRP1

TYRP1, also known as tyrosinase-related protein 1, is a human that encodes a melanosomal protein belonging to the tyrosinase family, playing a critical role in the biosynthetic pathway. Located on 9p23, the consists of 8 exons and produces a 537-amino-acid protein that contributes to eumelanin production, the dark responsible for , , and eye coloration, primarily through structural roles rather than direct enzymatic activity on 5,6-dihydroxyindole-2-carboxylic acid (DHICA). Expressed primarily in melanocytes of the , follicles, and , TYRP1 also stabilizes the enzyme —the rate-limiting step in synthesis—and influences maturation and structure. Mutations in TYRP1 are associated with type 3 (OCA3), a form of characterized by reduced pigmentation, often resulting in reddish-brown , ginger-red , and hazel or brown irises in affected individuals, particularly prevalent among dark-skinned populations in . Common mutations include the Ser166Ter and the 368delA frameshift deletion, both of which lead to a nonfunctional protein and impaired production. Beyond pigmentation disorders, TYRP1 has been implicated in progression, where it acts as a (gp75) targeted by , including recent CAR-T cell approaches as of , highlighting its dual role in normal physiology and cancer. Research continues to explore its regulatory mechanisms, including interactions with transcription factors like MITF, underscoring its importance in and overall pigmentary system integrity.

Genetics

Gene location and organization

The TYRP1 gene in humans is located on the short arm of chromosome 9 at position 9p23, with genomic coordinates spanning 12,693,385 to 12,710,285 in the GRCh38.p14 assembly, encompassing approximately 17 kb. In mice, the orthologous Tyrp1 gene resides on chromosome 4 at coordinates 80,752,360 to 80,769,973 in the GRCm39 assembly, covering about 18 kb. These positions highlight the syntenic conservation between human chromosome 9 and mouse chromosome 4, facilitating comparative genetic studies. The TYRP1 consists of 8 s and 7 introns, organized over its genomic span to encode a protein involved in melanogenesis. The promoter upstream of the first includes binding sites for the (MITF), which is essential for melanocyte-specific expression. In the model, the Tyrp1 corresponds to the classic (b) locus, where the Tyrp1^b disrupts normal pigmentation and serves as a key animal model for studying . TYRP1 exhibits high sequence conservation across mammalian species, reflecting its role in pigmentation. A 2023 comparative analysis of TYRP1 orthologs in diverse mammals revealed strong evolutionary preservation of functional domains, underscoring its contributions to pigmentation evolution and modulation of as an adaptive mechanism.

Sequence variants

The TYRP1 harbors several common single nucleotide polymorphisms (SNPs) that influence pigmentation traits and susceptibility. One prominent example is rs1408799, an intronic variant (c.1099-354T>C) associated with reduced risk of cutaneous , with an odds ratio of 0.77 (95% CI: 0.68-0.87) in genome-wide association studies of populations. The minor allele (C) has a frequency of approximately 0.167 in Northern and Western populations, such as those in the HapMap CEU panel, and shows linkage with variants influencing , including blue irides. Another notable common variant is rs61795860 (p.Arg93Cys, R93C), a missense change causing blond hair in Melanesian populations; its allele frequency reaches 0.26 in Solomon Islanders but is absent in 941 individuals across 52 global populations, indicating a population-specific . Pathogenic mutations in TYRP1 predominantly cause loss-of-function effects leading to type 3 (OCA3). A , c.368delA in 6, results in a premature at position 184 [p.(Arg123Glyfs*62)], producing a truncated protein lacking critical catalytic domains and causing complete loss of enzymatic activity; this variant was identified in an American individual with OCA3. Similarly, the c.977G>A (p.Arg326His, R326H) in 5 alters a conserved residue on the protein's periphery, disrupting two hydrogen bonds essential for and reducing DHCA activity by impairing . These are more prevalent in and Asian ancestries, with OCA3 accounting for up to 7% of cases in . Haplotype analyses reveal structured (LD) patterns in TYRP1, reflecting population-specific selection pressures on pigmentation. The R93C blond hair variant occurs on a distinct spanning ~100 kb around TYRP1, with high LD (r² > 0.8) to nearby SNPs and evidence of recent positive selection in populations, as indicated by extended haplotype homozygosity. In global contexts, TYRP1 s show elevated LD in non-coding regions, such as introns and the 3' (UTR), where variants like rs1834640 form blocks influencing regulatory element accessibility; these patterns differ by ancestry, with stronger LD in East Asians (average r² = 0.6) compared to Africans (r² = 0.3). Non-coding variants, particularly in the 3'UTR, modulate TYRP1 expression; for instance, the G of rs1834640 disrupts miR-155 binding, stabilizing mRNA and increasing protein output by up to 2-fold in allele-specific assays. Functional assays demonstrate how TYRP1 variants disrupt molecular processes. luciferase reporter studies of 3'UTR SNPs, such as rs1834640, reveal allele-dependent miR-155 repression, with the G enhancing efficiency and mRNA (from ~4 hours to 8 hours under miRNA overexpression), thereby elevating TYRP1 protein levels in cell lines. For pathogenic variants, expression of R326H in HEK293 cells shows reduced protein , with a 30% decrease in steady-state levels due to accelerated degradation, confirmed by assays; similarly, the 368delA frameshift abolishes full-length in minigene constructs, yielding only unstable truncated transcripts. These assays highlight variants' roles in impairing without altering splicing per se.
VariantTypeLocationMolecular EffectPopulation Frequency/ExampleReference
rs1408799 (intronic) 7Modulates expression; LD with lociMinor (C): 0.167 in Europeans
rs61795860 (R93C)Missense 3 (c.277C>T)Reduces protein stability; blond hair trait0.26 in Solomon Islanders
c.368delAFrameshift 6Truncated protein (p.Arg123Glyfs*62); loss of functionRare; reported in ancestry
c.977G>A (R326H)Missense 5Disrupts H-bonds; decreased stability/activityRare; OCA3 in diverse ancestries
rs1834640 (3'UTR)3'UTRAlters miR-155 ; affects mRNA stabilityVariable; G common in Asians (~0.4)

Protein

Primary structure and domains

The human TYRP1 protein consists of 537 and is synthesized as a type-1 transmembrane . It features an N-terminal spanning residues 1–24, which directs the protein to the secretory pathway, followed by a large intramelanosomal , a single transmembrane helix from residues 478–501, and a short cytoplasmic tail comprising residues 502–537. The primary structure includes several key functional domains within the intramelanosomal region. The N-terminal portion (residues 25–126) forms a cysteine-rich subdomain that adopts an (EGF)-like fold, stabilized by bonds between conserved residues (e.g., C42–C65, C56–C99, C101–C110), which may contribute to protein stability and interactions. This is followed by two metal-binding regions containing conserved residues (e.g., H215) that coordinate a binuclear , with the ions separated by approximately 3.5 and bridged by a / , differing from the coordination typical in related s. TYRP1 shares approximately 40% sequence identity with (TYR), with conserved motifs across these metal-binding domains. Post-translational modifications are critical for TYRP1 maturation and localization. The protein undergoes N-linked glycosylation at six asparagine residues (Asn96, Asn104, Asn181, Asn304, Asn350, Asn385), which are essential for proper folding, trafficking to melanosomes, and enzymatic activity. Additionally, occurs at five sites (Ser46, Ser137, Ser207, Thr222, Ser270), potentially influencing protein stability and regulatory interactions within melanocytes. Missense variants in the TYRP1 gene, such as those altering conserved residues in the metal-binding domains, can disrupt the primary sequence and lead to pigmentation disorders like type 3.

Three-dimensional structure

The three-dimensional structure of human TYRP1 was determined by in 2017 at a resolution of 2.35 (PDB : 5M8L), revealing a compact globular primarily within the luminal domain anchored to the membrane via a C-terminal transmembrane (residues 478–501). Higher-resolution structures were reported in 2024 at 2.23 (PDB : 9EY6) and 2.20 (PDB : 9EY8, in complex with (S)-amino-L-tyrosine), confirming the overall fold. The luminal portion (residues 25–477) comprises two main subdomains: an N-terminal cysteine-rich region (residues 25–126) adopting an (EGF)-like fold that stabilizes the overall structure through tight interactions with the adjacent tyrosinase-like core, and the core itself (residues 127–477) featuring a characteristic four- bundle typical of type-3 copper proteins, though adapted for coordination. Three extended loop insertions (residues 155–182, 199–204, and 291–300) protrude from the tyrosinase-like subdomain, providing flexibility that likely enables substrate access to the buried while maintaining structural integrity. At the heart of the tyrosinase-like core lies a binuclear metal , where two Zn²⁺ ions (ZnA and ZnB, separated by approximately 3.5 ) are coordinated by six conserved residues in a trigonal bipyramidal , bridged by a central or at about 2.1 distance. This configuration mirrors the canonical type-3 copper center of but substitutes for , precluding and instead supporting through bonds and π-stacking interactions, as exemplified by L-tyrosine near His381. Key coordinating residues include His215 ligating ZnA, with the overall -rich motif conserved across family members to facilitate metal incorporation during . Disease-associated mutations, such as R326H linked to oculocutaneous albinism type 3 (OCA3), disrupt this architecture; computational modeling based on the 5M8L structure predicts that R326H alters active site geometry, reduces metal coordination stability, and impairs overall protein folding without directly affecting the primary metal-binding histidines. In comparison to tyrosinase (TYR), which features a redox-active dicopper site, TYRP1's zinc center lacks the necessary electron transfer capability, while differing from TYRP2 (DCT) in surrounding residues (e.g., Tyr362, Arg374, Thr391 in TYRP1 versus equivalents in TYRP2) that shape the active site cleft for non-catalytic roles in melanogenesis intermediates like 5,6-dihydroxyindole-2-carboxylic acid (DHICA). These structural distinctions underscore TYRP1's evolution toward stabilization and transport functions rather than enzymatic turnover.

Biological function

Enzymatic activity in melanogenesis

TYRP1 catalyzes the oxidation of 5,6-dihydroxyindole-2-carboxylic acid (DHICA) to indole-5,6-quinone-2-carboxylic acid (IQCA), a critical step that promotes the formation of by facilitating the of carboxylated units into the polymer. This reaction occurs within the and integrates into the biosynthetic pathway downstream of (TYR), which generates dopachrome, and upstream of TYRP2, which acts as a dopachrome tautomerase to produce DHICA; together, these enzymes ensure efficient conversion of tyrosine-derived intermediates toward . The activity is particularly prominent in murine models, where it contributes to the reddish-brown pigmentation characteristic of wild-type . Enzyme kinetics for the DHICA oxidase activity reveal a Km value of approximately 0.8 for DHICA, indicating moderate compared to TYR's broader . The enzyme's function depends on bimetallic coordination in its , with copper ions enabling the chemistry necessary for oxidation in species where activity is observed, though TYRP1 predominantly binds ions, potentially limiting catalytic efficiency. Optimal activity occurs in the acidic environment of the (pH 5-6), aligning with the organelle's maturation and supporting sustained production. However, the DHICA oxidase role in humans is debated, with multiple studies reporting negligible activity for recombinant TYRP1, suggesting species-specific differences in catalytic function. Experimental evidence for TYRP1's enzymatic activity stems from assays using recombinant protein expressed in non-melanocytic cells, such as transfected fibroblasts, where purified TYRP1 demonstrated specific oxidation of DHICA to IQCA, measurable by spectrophotometric detection of products at around 490 nm. These assays confirmed substrate specificity, as TYRP1 showed minimal activity toward or other intermediates handled by TYR. Inhibition studies further support the oxidase mechanism, with phenylthiourea binding to TYRP1 and inhibiting the reaction, though it does not coordinate the metal ions. The 's binuclear metal center, involving ligands coordinating (or ), facilitates for the two-electron oxidation of DHICA.

Structural and non-enzymatic roles

TYRP1 serves as an within , where it contributes to the stabilization of the 's . This structural role is essential for maintaining the integrity of during melanin synthesis, as evidenced by studies showing that TYRP1 helps organize the internal architecture of these lysosome-related . Mutations in TYRP1, such as those observed in the mouse brown locus, result in defective maturation, leading to the accumulation of immature forms and compromised function. These structural defects are linked to broader cellular consequences, including reduced viability, with evidence indicating that TYRP1 deficiency promotes pathways, potentially through disrupted . Beyond its localization in melanosomes, TYRP1 acts as a molecular chaperone for (TYR), facilitating the proper folding and trafficking of this key melanogenic enzyme. By interacting with TYR in the (ER), TYRP1 prevents the retention and degradation of misfolded TYR, ensuring its delivery to melanosomes. Co-expression studies in melanocytic cell lines demonstrate that TYRP1 enhances TYR maturation, with wild-type TYRP1 rescuing trafficking defects in TYR mutants, thereby underscoring its chaperone function independent of enzymatic activity. This supportive role is particularly critical in maintaining the melanogenic complex, where TYRP1 stabilizes TYR without directly influencing its catalytic output. In addition to protein-mediated functions, TYRP1 mRNA exhibits a non-coding role by acting as a molecular sponge for microRNA-16 (miR-16) in cells. This occurs via non-canonical miRNA response elements, preventing miR-16 from repressing its target mRNAs, such as RAB17, which promotes . Experimental overexpression of TYRP1 mRNA in lines enhances in a translation-independent manner, while antisense targeting the miR-16 binding sites restore miR-16 activity and inhibit growth. This ceRNA (competing endogenous RNA) mechanism highlights TYRP1 mRNA's contribution to oncogenic processes through RNA-level regulation. TYRP1 also influences melanocyte survival and proliferation by modulating responses, as revealed through evolutionary and structural analyses. Adaptive changes in the TYRP1 gene across mammalian lineages suggest it bolsters defenses, mitigating (ROS) accumulation during melanogenesis. In Tyrp1-deficient models, elevated impairs , linking TYRP1's structural integrity to protection against ROS-induced damage and enhanced cellular resilience. This modulation supports homeostasis, with implications for pigmentation stability under environmental stressors.

Regulation

Transcriptional control

The expression of TYRP1 is primarily regulated at the transcriptional level by the (MITF), a basic helix-loop-helix (bHLH-LZ) protein that acts as the master regulator of development and differentiation. MITF binds to specific motifs in the TYRP1 promoter, including the M-box (AGTCATGTGCT) located approximately 197 base pairs upstream of the transcription start site and an adjacent (CAAGTG) at -238 to -233, thereby driving melanocyte-specific transcription of TYRP1. These binding events have been confirmed through (ChIP) and electrophoretic mobility shift assays (EMSA) in both and melanocytic cells, highlighting MITF's essential role in coordinating TYRP1 with other pigmentation genes. The core promoter of TYRP1 features a positioned upstream of the M-box, which facilitates basal transcription initiation in melanocytic lineages, along with proximal elements that integrate signals from upstream regulators. Distal enhancers, such as a conserved ~1.8 kb element approximately 15 kb upstream, contain binding sites for and contribute to melanocyte-specific activity by forming chromatin loops with the promoter via interactions with BRG1 chromatin remodelers. The promoter also harbors -responsive elements in two clusters (-121 to -42 bp), enabling activation by wild-type , p73α, and p63α in a dose-dependent manner. This allows responsiveness to environmental cues, including (UV) irradiation, which induces accumulation and links TYRP1 upregulation to the protective response by enhancing production. Additionally, cAMP signaling pathways, activated by melanocortin-1 receptor (MC1R) stimulation, potentiate MITF binding to the M- and E-boxes, thereby amplifying TYRP1 transcription without direct cAMP response elements () in the promoter. A 2025 study demonstrated that inhibits TYRP1 transcription by promoting lactylation at the promoter in B16 cells. During development, TYRP1 transcription is upregulated in parallel with melanoblast , where MITF transitions from a progenitor-promoting role to one that induces terminal markers like TYRP1. This regulation ensures coordinated expression in emerging melanocytes, with tissue-specific patterns observed in cutaneous melanocytes of , retinal pigment epithelium (RPE) of the eye, and follicular melanocytes during the anagen phase of the hair growth cycle. genes such as BMAL1 and PER1 further modulate TYRP1 in hair follicles, aligning pigmentation with physiological rhythms. Recent investigations have revealed that intracellular influences TYRP1 transcription, with transporters ZNT5-ZNT6 heterodimers and ZNT7 homodimers playing key roles in sustaining expression levels in melanocytes. Depletion of these transporters reduces TYRP1 mRNA and protein, impairing pigmentation, while supplementation restores transcriptional output, suggesting indirect modulation through metal-dependent signaling pathways that intersect with MITF activity. These findings underscore 's broader impact on melanogenic beyond enzymatic cofactors.

Post-transcriptional and post-translational regulation

Post-transcriptional regulation of TYRP1 primarily occurs through (miRNA) interactions with its 3' (3'UTR), which modulates mRNA stability and without altering transcription. The TYRP1 mRNA acts as a sponge for miR-16, a tumor-suppressor miRNA, by binding it via non-canonical miRNA response elements in the 3'UTR; this sequestration prevents miR-16 from repressing oncogenic targets like RAB17, thereby promoting and . In contrast, miR-155 binds canonically to the TYRP1 3'UTR, inducing mRNA and reducing TYRP1 protein levels, though this effect is antagonized by miR-16 binding. At the post-translational level, TYRP1 undergoes in the Golgi apparatus, which is essential for its proper folding and trafficking to melanosomes. N-linked at multiple sites in the TYRP1 luminal domain facilitates sorting from the trans-Golgi network into early endosomes, which serve as intermediates for delivery to stage II/III melanosomes via AP-3 and ESCRT-I-dependent pathways. Disruption of these sorting signals, such as dileucine motifs, impairs melanosomal targeting and leads to lysosomal misrouting. TYRP1 stability is further regulated by ubiquitination, which marks it for proteasomal or lysosomal degradation; in transporter-deficient cells, increased ubiquitination accelerates TYRP1 turnover, reducing its accumulation in melanosomes. TYRP1 enzymatic activity is modulated by post-translational modifications that influence kinetics and cofactor binding. of by C-β (PKC-β) at serine residues promotes its association with TYRP1, stabilizing the complex and enhancing DHICA oxidase activity, though direct kinetic alterations remain under investigation. TYRP1 function is zinc-dependent, requiring metalation by ZNT5-ZNT6 heterodimers or ZNT7 homodimers in the early secretory pathway; these transporters deliver Zn²⁺ to activate TYRP1's catalytic site, with their absence leading to immature, non-functional protein and impaired eumelanogenesis.

Molecular interactions

Protein-protein interactions

TYRP1 forms direct heterodimeric complexes with (TYR) primarily through interactions involving their luminal domains within the melanosomal . These complexes are stabilized by chemical crosslinking , with evidence from two-dimensional showing ~150 kDa heterodimers in and isolated melanosomes. Co-immunoprecipitation assays from lysates further confirm this association, demonstrating that TYRP1 co-precipitates with TYR under non-denaturing conditions. The N-terminal region of TYRP1, including residues critical for binding (e.g., affected by C86Y in Tyrp1^b mutants), is essential for this interface. TYRP1 also interacts with GIPC1 (GAIP-interacting protein C-terminal 1) via its C-terminal PDZ-binding motif, facilitating post-Golgi trafficking to melanosomes. This binding occurs transiently in the Golgi region of human melanocytes, as shown by and co-immunoprecipitation in cell lines, where GIPC1 co-precipitates with newly synthesized TYRP1. The GIPC1-TYRP1 complex links to APPL1 and PI3 kinase signaling, promoting efficient endosomal transport of TYRP1. In addition to TYR, TYRP1 associates with TYRP2 (dopachrome tautomerase, DCT) within pathway complexes, forming a stable heterotrimeric TYR-TYRP1-TYRP2 assembly. Computational docking models reveal 24 contact residues at the TYRP1-TYRP2 interface, with TYRP1 and TYRP2 binding to distinct surfaces of TYR, enabling potential substrate channeling during eumelanogenesis. TYRP1 exhibits potential with PMEL (premature melanosome protein) in immature s, suggesting a role in organization, as observed in studies of tyrosinase-knockout melanocytes. The cysteine-rich regions of TYRP1, particularly the epidermal growth factor-like subdomain (residues 25-126), contribute to structural stability through internal disulfide bonds (e.g., C30-C41, C290-C303), which indirectly support complex formation with TYR by maintaining the luminal domain conformation. Co-immunoprecipitation from melanocyte extracts has identified high-molecular-weight complexes involving TYRP1, TYR, and TYRP2, underscoring these motifs' role in multimeric assembly. These protein-protein interactions yield functional outcomes such as enhanced stability; for instance, the TYRP1-TYR prevents TYR aggregation and , as evidenced by accelerated TYR turnover in TYRP1-deficient melanocytes and rescue upon TYRP1 re-expression. Similarly, TYRP1 stabilization of TYR correlates with modulated activity in co-transfection assays.

Pathway involvement

TYRP1 plays a central role in the melanogenesis pathway as a enzyme in the eumelanin synthesis branch, where it acts downstream of the (MITF) as a DHICA , converting 5,6-dihydroxyindole-2-carboxylic acid (DHICA)—produced by TYRP2-mediated tautomerization of dopachrome—into indole-5,6-quinone-2-carboxylic acid (IQCA), thereby stabilizing (TYR) activity and promoting eumelanin production over pheomelanin. This integration into the MITF-driven pigment unit involves coordinated expression with TYR and tyrosinase-related protein 2 (TYRP2 or DCT), enhancing overall output in melanocytes under UV stimulation or hormonal signaling. In this pathway, TYRP1 also prevents the accumulation of toxic byproducts, ensuring efficient pigment granule maturation. In the response, TYRP1 modulates (ROS) levels by influencing intermediates that act as s, thereby protecting melanocytes from UV-induced damage and maintaining cellular during pigmentation. Evolutionary analyses indicate that structural variations in the TYRP1 gene have contributed to enhanced defense mechanisms in mammals, adapting to environmental pressures like solar radiation by optimizing ROS scavenging through eumelanin pathways. This role extends to broader , where TYRP1's activity helps balance ROS production during melanogenesis, preventing oxidative damage that could impair synthesis. TYRP1's non-coding mRNA exerts influence on proliferation signaling in contexts by sequestering miR-16, a that otherwise suppresses Wnt/β-catenin pathway components, thereby indirectly promoting cell growth and invasion without altering TYRP1's primary protein function. This regulatory interaction highlights TYRP1's dual role in pigmentation and oncogenic signaling networks. Within broader biochemical networks, TYRP1 intersects with metal pathways, particularly regulation, where zinc transporters such as ZNT5-ZNT6 heterodimers and ZNT7 homodimers are required for its proper expression, trafficking, and enzymatic stabilization in the early secretory pathway. This cross-talk ensures that TYRP1 function is zinc-dependent, linking pigmentation to cellular metal ion balance and potentially influencing biogenesis under varying physiological conditions.

Clinical and pathological significance

Role in pigmentation disorders

Mutations in the TYRP1 gene cause oculocutaneous albinism type 3 (OCA3), an autosomal recessive disorder characterized by reduced pigmentation in the skin, hair, and eyes. Individuals with OCA3, also known as rufous oculocutaneous albinism, typically exhibit reddish-brown skin and hair, ginger-red tones in some cases, and hazel or brown irises, along with mild to moderate visual impairments such as nystagmus and reduced visual acuity due to foveal hypoplasia. This form of albinism results from biallelic loss-of-function mutations that impair TYRP1's enzymatic role in eumelanin synthesis, leading to a predominance of pheomelanin and overall hypopigmentation; for example, the frameshift mutation 368delA has been identified in affected individuals from African populations. OCA3 is particularly prevalent among people of Southern African descent, where it accounts for a significant proportion of albinism cases, though it occurs worldwide at lower frequencies. Beyond , certain TYRP1 variants contribute to normal pigmentation variations in human populations. In , particularly Solomon Islanders, the recessive encoding p.Arg163Gln (rs61776988) in TYRP1 reduces eumelanin production, resulting in naturally blond hair among individuals with pigmentation; this variant is carried by about 26% of Solomon Islanders and acts through diminished TYRP1 catalytic activity. In Europeans, the TYRP1 variant rs1408799*A is associated with lighter tones, influencing levels and contributing to population-level differences in pigmentation. These polymorphisms highlight TYRP1's role in modulating eumelanin synthesis without causing pathological . Animal models of TYRP1 dysfunction recapitulate pigmentation defects observed in humans. In mice, the recessive , arising from a , produces a color due to diluted eumelanin and altered structure. Similarly, in , mutations such as a 6-bp deletion in TYRP1 8 lead to color, characterized by reduced eumelanin and altered structure in and . These models demonstrate conserved functions of TYRP1 across species, including maintenance of integrity and eumelanin polymerization. Diagnosis of TYRP1-related pigmentation disorders relies on clinical evaluation combined with molecular and biochemical testing. Genetic panels for sequence TYRP1 alongside other genes (e.g., TYR, OCA2) to identify biallelic variants, confirming OCA3 in cases with compatible phenotypes; sequencing detects mutations like frameshifts or missense changes that abolish protein function. Biochemical assays, such as measuring DHICA activity in extracts, can demonstrate absent or reduced enzymatic function in affected individuals, supporting the genetic findings and distinguishing TYRP1 defects from other subtypes.

Implications in melanoma and cancer

TYRP1 expression serves as a prognostic marker in metastatic melanoma, where elevated levels of TYRP1 mRNA in tumor metastases, particularly in skin and lymph nodes, correlate with unfavorable clinical outcomes and reduced overall survival. This association has been observed in patient cohorts, with high TYRP1 expression linked to increased tumor proliferation and invasive potential, contributing to disease progression. Beyond its coding function, TYRP1 mRNA acts as a non-coding by sequestering the tumor-suppressive miR-16 through non-canonical binding sites, thereby preventing miR-16 from repressing its target genes involved in regulation and , such as RAB17. This sponging mechanism promotes cell , as demonstrated in preclinical models where depletion of TYRP1 mRNA reduced tumor and growth in patient-derived xenografts. Therapeutic strategies targeting TYRP1 show promise in melanoma treatment, with genetic variants such as the SNP rs1408799 in TYRP1 associated with altered risk (OR 0.77, indicating a protective effect for the variant allele). Approaches including chimeric receptor (CAR) T-cell therapy and T-cell engaging bispecific antibodies directed against TYRP1 have demonstrated antitumor activity in preclinical models of cutaneous, uveal, and acral , potentially enhancing efficacy when combined with inhibitors like PD-1 blockade, as suggested by studies on the family. In other malignancies, TYRP1 is overexpressed in approximately 90% of uveal melanomas, making it a viable target for immunotherapies in this subtype. Additionally, TYRP1 contributes to tolerance within the , supporting cancer cell survival under hypoxic and ROS-elevated conditions prevalent in progression.

References

  1. [1]
    TYRP1 tyrosinase related protein 1 [ (human)] - NCBI
    Sep 5, 2025 · This gene encodes a melanosomal enzyme that belongs to the tyrosinase family and plays an important role in the melanin biosynthetic pathway ...
  2. [2]
    TYRP1 gene: MedlinePlus Genetics
    The TYRP1 gene provides instructions for making an enzyme called tyrosinase-related protein 1. This enzyme is located in melanocytes.
  3. [3]
    Fifteen-year quest for microphthalmia-associated transcription factor ...
    ... TYRP1 and DCT genes, encoding the three enzymes involved in melanin synthesis or melanogenesis ... In this review, we provide an overview of the MITF ...
  4. [4]
    Tyrp1 tyrosinase-related protein 1 [ (house mouse)] - NCBI
    NZG/Kgm mouse has two recessive pigmentation variant genes (oca2(p) and tyrp-1(b)) and that the tyrp-1(b) gene locus associates with large body ...
  5. [5]
    115501 - TYROSINASE-RELATED PROTEIN 1; TYRP1 - OMIM
    TYRP1, also known as TYROSINASE-RELATED PROTEIN 1, is located at 9p23 and is related to skin/hair/eye pigmentation and oculocutaneous albinism.
  6. [6]
    Human TYRP1: Two functions for a single gene? - Gautron - 2021
    Dec 11, 2020 · This gene is located on chromosome 9 ... Identification of mutations in the pigment cell-specific gene located at the brown locus in mouse.
  7. [7]
    Comparative evolutionary and structural analyses of the TYRP1 ...
    This study conducted a comparative analysis of tyrosine protein across different mammalian species to gain insight into the molecular mechanisms of adaptive ...
  8. [8]
    TYRP1 (tyrosinase-related protein 1)
    Apr 1, 2016 · ... TYRP1 protein in a subgroup of melanoma patients. TYRP1 SNP rs1408799 has been found to be associated with melanoma risk (OR, 0.77; 95% CI ...
  9. [9]
    Personalized Report - rs1408799 - Infinome
    This gene encodes a melanosomal enzyme that belongs to the tyrosinase family and plays an important role in the melanin biosynthetic pathway.
  10. [10]
    Human pigmentation genes under environmental selection
    Sep 27, 2012 · In the European population TYRP1 rs1408799*A has been associated with blue eye color [24, 25], though other SNPs are also associated with blue ...
  11. [11]
    Melanesians blond hair is caused by an amino acid change in TYRP1
    The novel mutation is at a frequency of 26% in the Solomon Islands but is absent outside of Oceania and represents the largest genetic effect on a visible human ...
  12. [12]
    Tyrp1 Mutant Variants Associated with OCA3 - PubMed - NIH
    Sep 22, 2021 · Four OCA3-causing mutations of Tyrp1, C30R, H215Y, D308N, and R326H, were investigated computationally to understand Tyrp1 protein stability and catalytic ...
  13. [13]
    Tyrp1 Mutant Variants Associated with OCA3 - PubMed Central - NIH
    Sep 22, 2021 · R326H is also located on the periphery of Tyrp1. The mutation from arginine to histidine (R326H) removes the two transient hydrogen bonds ...
  14. [14]
    Complex signatures of selection for the melanogenic loci TYR ...
    Feb 29, 2008 · We observe strong evidence for positive selection for TYRP1 alleles in Africans and for DCT and TYRP1 in Asians. However, the overall picture reflects a ...
  15. [15]
    Timing of Pigmentation Lightening in Europeans - Oxford Academic
    Aug 25, 2012 · 2007). The tag for TYRP1 is a highly conserved intronic SNP in strong linkage disequilibrium with variants (rs2733832, r2 = 0.9 and rs1408799, r ...
  16. [16]
    SNPs at miR-155 binding sites of TYRP1 explain discrepancy ...
    Polymorphisms in 3′UTR of TYRP1 mRNA can affect TYRP1 mRNA regulation by miR-155 and its subsequent translation into protein. These SNPs can render TYRP1 mRNA ...
  17. [17]
    In vitro characterization of the intramelanosomal domain of human ...
    Nov 22, 2022 · However, Kamaraj and Purohit (2013) using the computational analysis, found R326H as the most deleterious and disease-associated TYRP1 mutation.
  18. [18]
    In vitro characterization of the intramelanosomal domain of human ...
    Here, to investigate the effect of genetic mutations on the human TYRP1 structure, function, and stability, we expressed and purified the intramelanosomal ...Missing: mRNA translation
  19. [19]
    Structure of Human Tyrosinase Related Protein 1 Reveals a ... - NIH
    The subdomain is located far from the active site, at the opposite side of the molecule (Figure 1 B), making a direct effect on the activity of TYRP1 unlikely.
  20. [20]
    TYRP1 - 5,6-dihydroxyindole-2-carboxylic acid oxidase - UniProt
    TYRP1_HUMAN, also known as 5,6-dihydroxyindole-2-carboxylic acid oxidase, plays a role in melanin biosynthesis and catalyzes the oxidation of DHICA.
  21. [21]
  22. [22]
  23. [23]
    Tyrosinase related protein 1 (TRP1) functions as a DHICA oxidase ...
    Dec 15, 1994 · The data demonstrate that the specific melanogenic function of TRP1 is the oxidation of 5,6-dihydroxyindole-2-carboxylic acid (DHICA) to a carboxylated indole- ...Missing: primary sources<|control11|><|separator|>
  24. [24]
    Phenylthiourea Binding to Human Tyrosinase-Related Protein 1
    Jan 30, 2020 · Phenylthiourea, a highly potent tyrosinase inhibitor, does neither coordinate the active site zinc ions, but binds differently from other structurally ...
  25. [25]
    Mutant alleles at the brown locus encoding tyrosinase ... - PubMed
    Mutation in the Tyrp1 gene is associated with brown pelage in mouse and oculocutaneous albinism Type 3 in humans (OCA3).
  26. [26]
    In silico screening and molecular dynamics simulation of ... - PubMed
    Tyrp1 is also involved in maintenance of melanosome structure and affects melanocyte proliferation and cell death. In this work we implemented computational ...
  27. [27]
    The TYRP1-mediated protection of human tyrosinase activity does ...
    TYRP1 catalyzes the oxidation of 5,6-dihydroxyindole-2-carboxylic acid (DHICA) into indole-5,6-quinone-2-carboxylic acid (IQCA), and TYRP2 is responsible for ...
  28. [28]
    Oculocutaneous albinism types 1 and 3 are ER retention diseases
    Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild- type ...Missing: co- | Show results with:co-
  29. [29]
    Regulation of Tyrosinase Processing and Trafficking by Organellar ...
    In this study, we examined the expression, processing, and trafficking mechanisms of various melanosomal proteins (TYR,. TYRP1, DCT, gp100, and MART1) in ...
  30. [30]
    A non-coding function of TYRP1 mRNA promotes melanoma growth
    Here, we report that TYRP1 mRNA, in addition to encoding tyrosinase-related protein 1 (TYRP1), indirectly promotes cell proliferation by sequestering miR-16 on ...Missing: sponge | Show results with:sponge
  31. [31]
    miRNA displacement as a promising approach for cancer therapy
    TYRP1 mRNA endorses an endogenous miRNA sponge function forming a 'super competing endogenous RNA (ceRNA)'. Sequestered miR-16 is no longer able to repress its ...
  32. [32]
    MITF-M-dependent TYRP1 gene expression - Reactome
    TYRP1 has cAMP-responsive M- and E- box elements in its promoter that are bound by MIITF-M as demonstrated by ChIP and EMSA in mouse and human cells.
  33. [33]
    The master role of microphthalmia-associated transcription factor in ...
    Mar 6, 2017 · MITF promotes differentiation through regulating pigmentation genes including TYR, TYRP1, DCT, PMEL, and MLANA; has pro-survival roles through ...
  34. [34]
    Transcriptional activation of tyrosinase and TRP-1 by p53 links UV ...
    Transcriptional activation of tyrosinase and TRP-1 by p53 links UV irradiation to the protective tanning response. J Pathol. 2000 Jan;190(1):39-46. doi ...
  35. [35]
    Pigmentation and TYRP1 expression are mediated by zinc through ...
    Apr 18, 2023 · In this study, we provide evidence that melanogenesis is dependent on zinc transporters ZNT5–6 and ZNT7, which are known to supply zinc to ...Missing: comparative | Show results with:comparative
  36. [36]
    ESCRT-I function is required for Tyrp1 transport from early ... - NIH
    Here we show that early endosomes are requisite intermediates in the trafficking of Tyrp1 from the Golgi to late stage melanosomes in normal melanocytic cells.
  37. [37]
    Mechanisms of Protein Delivery to Melanosomes in Pigment Cells
    Apr 1, 2012 · This review describes current models of protein trafficking required for melanosome biogenesis in mammalian melanocytes.
  38. [38]
    Protein kinase C-beta-mediated complex formation ... - PubMed
    These results suggest that phosphorylation of tyrosinase by PKC-beta induces a complex formation between tyrosinase and TRP-1. Publication types. Research ...Missing: kinetics | Show results with:kinetics
  39. [39]
    Establishment of a synchronized tyrosinase transport system ...
    Jan 30, 2024 · We were able to demonstrate that Tyr-related protein 1 (Tyrp1), another melanogenic enzyme, is a positive regulator of efficient Tyr targeting to immature ...
  40. [40]
    Direct interaction of tyrosinase with Tyrp1 to form heterodimeric ...
    Dec 15, 2007 · Taken together, these data demonstrate that Tyrp1 interacts directly with Tyr in vivo, which may regulate the stability and trafficking of ...<|separator|>
  41. [41]
    Interactions between GIPC–APPL and GIPC–TRP1 regulate ...
    In previous studies we showed that, in epidermal melanocytes, GIPC interacts with newly synthesized melanosomal protein TRP1 in the Golgi region and proposed ...Missing: TYRP1 | Show results with:TYRP1
  42. [42]
    Biophysical Compatibility of a Heterotrimeric Tyrosinase-TYRP1 ...
    Apr 28, 2021 · There are two copper binding sites required for catalytic activity, 7N-glycosylated asparagine residues and three cysteine-rich regions required ...Missing: motif HxHRxHE<|separator|>
  43. [43]
    High-molecular-weight forms of tyrosinase and the ... - PubMed
    Antibodies to TRP-1 and TRP-2 immunoprecipitated tyrosinase activity, suggesting a stable interaction (complex) among these proteins. ... Tyrp1 protein, mouse ...<|control11|><|separator|>
  44. [44]
    Mutational analysis of the modulation of tyrosinase by ... - PubMed
    We report evidence that Tyrp1 stabilizes tyrosinase, confirming previous observations, and, in addition, demonstrate that Tyrp1 decreases tyrosinase activity.
  45. [45]
    The roles of Microphthalmia Transcription Factor and pigmentation ...
    ... tyrosinase-related protein 1 (TYRP1) are MITF targets that encode enzymes necessary for melanin synthesis. MITF also regulates Absent In Melanoma-1 (AIM-1) ...
  46. [46]
    Signaling Pathways in Melanogenesis - MDPI
    However, it has been shown that TYRP1 and -2 don't have cAMP response elements (CREs) in their promoter regions. It is believed that the regulation of these ...
  47. [47]
    Oxidative stress in melanogenesis and melanoma development - PMC
    The markers of the melanin synthesis pathway are tyrosinase, Tyrp1 and Tyrp2/DCT. The oxidative stress pathway consists of several genes either negatively or ...
  48. [48]
    Comparative evolutionary and structural analyses of the TYRP1 ...
    Jun 6, 2023 · Comparative evolutionary and structural analyses of the TYRP1 gene reveal molecular mechanisms of biological functions in mammals. June 2023 ...
  49. [49]
    The metabolism of melanin synthesis—From melanocytes to ...
    Mar 6, 2024 · TR1 levels are raised by UV-induced and endogenous oxidative stress and the Trx/TR1 system responds by scavenging ROS and signaling to increase ...
  50. [50]
    Noncoding RNA:RNA Regulatory Networks in Cancer - PMC - NIH
    Another study also outlined the sequestration of an abundant miRNA, miR-16, by TYRP1 (tyrosinase-related protein 1) mRNA in melanoma [42]. Although there were ...
  51. [51]
    Pigmentation and TYRP1 expression are mediated by zinc ... - NIH
    Apr 18, 2023 · The insertion of copper ions into TYR occurs during its biosynthesis in the secretory pathway, which is mediated by the ATP7A copper transporter ...Missing: HxHRxHE | Show results with:HxHRxHE
  52. [52]
    Tyrp1 and oculocutaneous albinism type 3 - PubMed
    Tyrp1 is also involved in maintenance of melanosome ultrastructure and affects melanocyte proliferation and melanocyte cell death. The current review is an ...
  53. [53]
    Oculocutaneous Albinism (TYRP1 gene) - tellmeGen
    Oculocutaneous albinism type 3 (OCA3) is caused by mutations in the TYRP1 gene, which hinders eumelanin production. More common in individuals of Southern ...
  54. [54]
    The mouse brown (b/Tyrp1(b) ) allele does not affect pheomelanin ...
    B (Tyrp1 (+)), the wild type allele at the mouse brown locus, produces black eumelanin, while b (Tyrp1(b) ), the recessive allele, produces brown eumelanin ...Missing: models | Show results with:models
  55. [55]
    A 6-bp deletion in the TYRP1 gene causes the brown colouration ...
    Oct 27, 2010 · The findings provide the compelling evidence that brown colours in Chinese indigenous pigs are caused by the same ancestral mutation in TYRP1.
  56. [56]
    Oculocutaneous albinism - Orphanet Journal of Rare Diseases
    Nov 2, 2007 · At least four genes are responsible for the different types of the disease (TYR, OCA2, TYRP1 and MATP). Diagnosis is based on clinical findings ...
  57. [57]
    TYRP1 mRNA expression in melanoma metastases correlates ... - NIH
    Nov 1, 2011 · Our data indicate that TYRP1 mRNA expression level, at least in skin metastases, is a prognostic marker for melanoma.Missing: TCGA HR
  58. [58]
    Tyrosinase-related protein 1 mRNA expression in lymph node ...
    Mar 21, 2013 · High TYRP1/S100B mRNA expression in lymph node metastases from melanoma patients is associated with unfavourable clinical outcome.Missing: TCGA | Show results with:TCGA
  59. [59]
    TYRP1 mRNA goes fishing for miRNAs in melanoma - PubMed
    Oct 31, 2017 · The mRNA of TYRP1 is now found to sequester the tumour suppressor miR-16 on non-canonical miRNA response elements in melanoma, thereby promoting malignant ...
  60. [60]
    [PDF] Human TYRP1: two functions for a single gene? - HAL
    Feb 4, 2021 · This gene is located on chromosome. 9 (9p23) at base pairs 12,693,385 to 12,710,266 in the NCBI GRCh38/hg38 assembly. It encodes the human ...
  61. [61]
    Genetic variants in pigmentation genes, pigmentary phenotypes ...
    The SNP rs17426596 is the only one with minor allele frequency >1% in the HapMap CEU samples. Recently, an eye-color variant in TYRP1 (rs1408799) was reported ...
  62. [62]
    CAR-T cell therapy targeting surface expression of TYRP1 to treat ...
    Feb 9, 2024 · Here, we identify Tyrosinase Related Protein 1 (TYRP1) as a CAR-T cell therapy target to treat patients with cutaneous and rare melanoma ...
  63. [63]
    TYRP1 directed CAR T cells control tumor progression in preclinical ...
    Aug 22, 2024 · TYRP1-targeted CAR T cells demonstrate antigen-specific activation and cytotoxic activity in vitro and in vivo against human melanomas ...Missing: prognosis | Show results with:prognosis
  64. [64]
    Tyrosinase in melanoma inhibits anti-tumor activity of PD-1 deficient ...
    May 15, 2025 · Inhibiting tyrosinase could enhance the effectiveness of PD-1 blockade, offering a new approach for melanoma patients who fail in current PD ...Missing: TYRP1 | Show results with:TYRP1
  65. [65]
    Promising target for CAR T-cell therapy leads to potent antitumor ...
    Feb 16, 2024 · The authors showed that 60% of patients with acral and mucosal melanoma and around 90% of patients with uveal melanoma overexpress TYRP1.
  66. [66]
    TYRP1 | Cancer Genetics Web
    Specific Cancers (3). Data table showing topics related to specific cancers and associated disorders. Scope includes mutations and abnormal protein expression.Missing: 100delC | Show results with:100delC